Endocrine Abstracts

Background: Central hypothyroidism can be difficult to diagnose as TSH values often reside within the normal range. The Endocrine Society clinical guideline for hormone replacement in hypopituitarism suggests levothyroxine is indicated for treatment of secondary hypothyroidism where fT4 levels decrease by ≥20%. To determine the reliability of this biochemical marker of secondary hypothyroidism we evaluated evolution of TFTs over time within a cohort of NFPA.<p class=...

Aim: Hypothyroidism is a common chronical disease worldwide, leading to a lifelong metabolic slowdown that can have a significant negative impact on the quality of life, both physiologically and psychologically. Despite achieving euthyroidism with replacement, there is evidence that symptoms persist. In this study, we aim to examine the effectiveness of thyroid hormone replacement and the effect of autoimmunity from a clinical-biochemical point of view by evaluating the euthyr...

Background: Dysmetabolic iron overload syndrome (DIOS) is characterized by elevated ferritin and normal transferrin saturation level. Iron metabolism may be linked to the sympathetic overactity. DIOS is seen in 15–20% of the metabolic syndrome cases.Aim: This study aimed to test the hypothesis linking the increased baseline sympathetic drive to the hypertension seen in dysmetablolic iron overload syndrome in cases of metabolic syndrome.<p class=...

Background: Exercise training has become an important adjunct therapy for both the prevention and management of type II diabetes mellitus. Interest in telemedicine is increasing as a potentially innovative and sustainable intervention approach to diabetes management. Telemedicine can facilitate the achievement of individualized treatment goals by training patients to manage their own disease.Objective: To evaluate the effect of telemedicine on exercise c...

Cushing’s syndrome (CS) is a disease entity that through hypercortisolism affects all body’s tissues leading to increased morbidity, decreased quality of life and mortality. Muscles are among the tissues primarily affected. However, data on the impact of endogenous hypercortisolism on functional muscle capacity and daily physical activity levels are scarce. We studied 23 subjects with endogenous CS (mean age: 40.73±2.17 years) and 22 healthy aged and sex matched...

The incidence of Alzheimer’s disease (AD) is higher in women than men. Our study aimed to investigate the behavioral, biochemical, and histological changes in lipopolysaccharide (LPS)-induced AD, to study effect of estrogen in AD clarifying the possible involved underlying mechanisms and its modulation by progestsserone. Groups: Female albino rats were divided into control, AD, AD+ovariectomy (OVX), AD+OVX+estrogen replacement and AD+OVX+estrogen+pr...

Introduction: Thalassemia manifests clinically as anemia requiring life-long blood transfusions and the chronic iron deposition . Iron overload can lead to decreased functioning of the respective systems. Thalassemia-associated osteoporosis constitutes a majorproblem. Weinvestigated the bone mineral density scores of the thalassemic patients and correlated the scores of themwith some parameters including the transfusion frequency, levels of ferritin and pituitary hormones....

An 89-year-old female family physician presented to an orthopaedic surgeon with a short history of aches and pains. She was suspected to have vitamin D deficiency and was empirically prescribed three intramuscular injections of 6 million units of cholecalciferol at monthly intervals. A few days after the third dose she presented with nausea, generalised weakness, confusion and ataxia. She appeared drowsy and dehydrated. Vital parameters were normal and there were no focal neur...

Background: We analyzed in the vitamin D3 receptor gene (VDR) polymorphism can modulate therapeutic response of functional hypothalamic amenorrhea (FHA) patients to the estroprogestagen (EP) treatment.Material and methods: The study included 84 FHA girls and 50 controls. FHA patients underwent a 4-year sequential EP therapy with 17-β estradiol (2 mg from the 2nd to 25th day of the menstrual cycle) and didrogesterone (10 mg from the 16th to the 25th ...

The aim of this study was to verify if genetic factors influence the short- and long-term therapeutic response to estroprogestagen (EP) therapy implemented in girls with functional hypothalamic amenorrhea (FHA) in order to improve their bone mineral density (BMD). The study included 78 FHA girls who underwent a 4-year sequential EP therapy with 17β-estradiol and didrogesterone. Changes in the lumbar spine BMD were determined at the end of the therapy and 6 years after its...